We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Abbott to Develop Preeclampsia Test

By HospiMedica staff writers
Posted on 02 Aug 2005
Under a recent agreement, worldwide semi-exclusive rights to commercialize products using patents of Nephromics (Chestnut Hill, MA, USA) related to two proteins for detecting and monitoring preeclampsia have been granted to Abbott Laboratories (Abbott Park, IL, USA). More...


Abbott intends to develop an in vitro diagnostic test to detect preeclampsia. There is currently no specific diagnostic test for this life-threatening disease that affects many pregnant women each year. "Abbott's goal is to develop prenatal tests that could be utilized for early risk stratification of pregnancy complications,” explained William Brown, Ph.D., vice president, diagnostic assays and systems development, Abbott Labs.

Abbott has a history of developing endocrine and other hormone-related tests and offers a broad range of innovative instrument systems and tests across key segments of the global diagnostics market. Immunodiagnostics is a core component of the company's medical products business.

"Because preeclampsia can strike quickly, potentially causing severe and immediate complications such as seizures and organ failure that threaten both the health of the baby and mother unless pregnancy is induced, early diagnostic tests are needed,” observed David Barch, M.D., medical director, Abbott Diagnostics. "These tests would be developed for use on our premier diagnostic analyzer, the Architect integrated immunoassay and clinical chemistry system.”




Related Links:
Abbott

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: SportSuite Vision integrates arthroscopic video, HipCheck, HipMap, and CT imaging within a customizable spatial computing environment, allowing surgeons to view anatomy and digital tools in one ergonomic field of view (Photo courtesy of Stryker)

Augmented Reality System Integrates Intraoperative Data for Hip Arthroscopy

Stryker’s (Portage, MI, USA) SportSuite Vision is a surgical application for Apple Vision Pro that brings key clinical content into the surgeon’s visual space. On September 1, 2026, the company announced... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.